Instituto Rosenbusch S.A.

BCBA-ROSE
Buenos Aires Stock Exchange
Healthcare Drug Manufacturers - Specialty & Generic
Global Rank
#43083
Country Rank
#66
Market Cap
6.48 M
Price
0.152
Change (%)
5.33%
Volume
83,274

Instituto Rosenbusch S.A. (BCBA-ROSE) Stock Split History

Date Split Ratio Multiple Cumulative multiple Type
11/16/2011 1.436:1 x1.436 x4.778223 Forward
11/21/2007 1.2:1 x1.2 x3.327453 Forward
08/05/2004 2.197:1 x2.197 x2.772878 Forward
08/13/2001 1.135:1 x1.135 x1.26212 Forward
08/06/1999 1.112:1 x1.112 x1.112 Forward

Frequently Asked Questions

  • How much would Instituto Rosenbusch S.A. stock be worth if it never split?
    If Instituto Rosenbusch S.A. (stock symbol: BCBA-ROSE) had never undergone any stock splits, its price per share today would be approximately 0.73 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 1.436-for-1) that occurred on 11/16/2011.
  • Instituto Rosenbusch S.A. (stock symbol: BCBA-ROSE) has undergone a total of five stock splits. The most recent split occurred on 11/16/2011. One share bought prior to the first split on 08/06/1999 would now equal 4.78 shares.
  • Instituto Rosenbusch S.A. (stock symbol: BCBA-ROSE) has undergone five stock splits in its history. The most recent split, a 1.112-for-1 split, occurred on 11/16/2011. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.